TGA Approval

XOLAIR omalizumab (rch) 150mg powder for injection vial with diluent ampoule (82744)

ARTG ID

82744

ARTG Name

XOLAIR omalizumab (rch) 150mg powder for injection vial with diluent ampoule

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

June 13, 2002

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/1e4737624f1cc4403a9f94950f01e4d6.pdf

https://medical-cdn.nocode.com/drug_tga/13cfbe8c8418e9d2e42d9eeb9686aaf6.pdf

Ingredient Name

Omalizumab

Empowering clinical research with data-driven insights and AI-powered tools.

XOLAIR omalizumab (rch) 150mg powder for injection vial with diluent ampoule (82744) - TGA 批准文号 | MedPath